Alzheimer’s disease is the most common form of dementia and affects millions of people around the world.
The disease mainly develops in older adults and gradually damages memory, thinking, and daily functioning.
As the condition progresses, people may struggle to recognize loved ones, communicate clearly, or carry out routine activities. Despite decades of research, scientists are still searching for effective ways to prevent or stop the disease.
One of the hallmarks of Alzheimer’s disease is the buildup of abnormal proteins in the brain. Among these proteins is tau, a substance that normally plays an important role in keeping nerve cells healthy.
Under normal conditions, tau helps maintain the internal structure of nerve cells, acting like a support system that keeps important transport pathways functioning properly.
These transport pathways are essential because they move nutrients, signals, and other materials throughout the cell. Without a healthy transport system, nerve cells cannot function correctly.
In Alzheimer’s disease, however, tau proteins undergo harmful changes. Instead of remaining in their normal shape, they begin to fold incorrectly and stick together.
Over time, these abnormal tau proteins form long twisted fibers known as fibrils. As more fibrils accumulate inside nerve cells, they interfere with the cell’s transport system and eventually contribute to cell death.
Scientists have known about tau fibrils for many years, but exactly how they first develop has remained unclear. Most studies have focused on the later stages of the disease, when large fibrils are already present. A new study from researchers at Tokyo Metropolitan University has taken a different approach by investigating the very beginning of the process.
The research was led by Professor Rei Kurita and his team. Instead of looking only at the final fibrils, they focused on what happens before these structures appear.
To do this, the scientists borrowed ideas from polymer physics, a field that studies long chain-like molecules called polymers. Researchers in this field have learned that polymers often do not form crystals immediately. Instead, they first gather into small, soft clusters before gradually developing into larger, more organized structures.
The team wondered whether tau proteins might behave in a similar way.
To test this possibility, they studied tau proteins suspended in a liquid solution. Their experiments revealed that tau proteins do not instantly transform into fibrils. Instead, they first come together to form tiny clusters made up of small groups of proteins.
These clusters were extremely small, measuring only a few nanometers across. They were also soft and unstable, unlike the rigid fibrils seen in Alzheimer’s disease. Importantly, the clusters were reversible, meaning they could easily break apart under certain conditions.
The researchers used advanced scientific techniques, including X-ray scattering and fluorescent dyes, to confirm the presence of these tiny clusters. The results provided strong evidence that these early protein groupings exist before fibrils begin to form.
Next, the team explored whether preventing the clusters would also stop fibril formation. They changed the conditions of the solution by adjusting salt concentrations and adding a substance called heparin.
The results were striking. When the conditions prevented the tiny clusters from forming, tau fibrils failed to develop as well. This finding suggests that the soft clusters may act as an essential first step in the creation of harmful tau fibrils.
The researchers believe that increasing salt levels weakens the interaction between tau proteins and heparin. As a result, the proteins are less likely to gather together into clusters. Without these early clusters, the chain of events leading to fibril formation may be interrupted.
This discovery could have important implications for future Alzheimer’s treatments. Most current research strategies focus on removing or breaking apart large protein deposits after they have already formed. However, by that stage, significant damage may already have occurred inside the brain.
The new findings suggest that targeting the earliest stages of tau aggregation could be a more effective approach. Preventing the formation of soft protein clusters may stop fibrils from developing in the first place, potentially slowing or even preventing disease progression.
The idea may also have broader applications beyond Alzheimer’s disease. Several neurological disorders, including Parkinson’s disease and other forms of dementia, involve the buildup of abnormal proteins. If similar early clustering processes occur in these conditions, future treatments might be able to target these early steps as well.
The study highlights how important it is to understand the earliest biological changes that occur during disease development. Sometimes the most effective treatment strategies are those that intervene before major damage takes place.
Although much more research is needed before these findings can be translated into therapies for patients, the discovery provides an encouraging new direction for scientists studying Alzheimer’s disease.
By focusing on the tiny protein clusters that appear before fibrils form, researchers may have identified a new opportunity to stop the disease at its earliest stages.
If you care about Alzheimer’s, please read studies about the likely cause of Alzheimer’s disease , and new non-drug treatment that could help prevent Alzheimer’s.
For more health information, please see recent studies about diet that may help prevent Alzheimer’s, and results showing some dementia cases could be prevented by changing these 12 things.
The study was published in the journal Neuroscience Research.
Copyright © 2026 Knowridge Science Report. All rights reserved.
